TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East & Africa Embolotherapy Market – by Product
1.3.2 Middle East & Africa Embolotherapy Market – by Disease Indication
1.3.3 Middle East & Africa Embolotherapy Market – by Procedure
1.3.4 Middle East & Africa Embolotherapy Market – by End User
1.3.5 Middle East & Africa Embolotherapy Market– By Country
2. Middle East & Africa Embolotherapy Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Embolotherapy Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinion
5. Middle East & Africa Embolotherapy Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Boosting Incidence of Cancer Cases
5.1.2 Surging Incidence of Hypertension, Obesity, Smoking, and Alcoholism
5.2 Market Restraints
5.2.1 Presence of Other Alternative Therapies
5.3 Market Opportunity
5.3.1 Widening Applications of Embolotherapy
5.4 Market Trend
5.4.1 Higher Use of Liquid Embolic Agents
5.5 Impact analysis
6. Middle East & Africa Embolotherapy Market Analysis
6.1 Middle East & Africa Embolotherapy Market Revenue Forecast and Analysis
7. Middle East & Africa Embolotherapy Market – by Product
7.1 Overview
7.2 Middle East & Africa Embolotherapy Market Revenue Share, by Products 2022 & 2028 (%)
7.3 Embolic Agents
7.3.1 Overview
7.3.2 Embolic Agents: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.3.3 Microspheres
7.3.3.1 Overview
7.3.3.2 Microspheres: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.3.4 Embolic Coils
7.3.4.1 Overview
7.3.4.2 Embolic Coils: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.3.5 Embolic Plug Systems
7.3.5.1 Overview
7.3.5.2 Embolic Plug Systems: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.3.6 Detachable Balloons
7.3.6.1 Overview
7.3.6.2 Detachable Balloons: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.3.7 Liquid Embolic Agents
7.3.7.1 Overview
7.3.7.2 Liquid Embolic: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.3.8 Others
7.3.8.1 Overview
7.3.8.2 Others: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.4 Support Devices
7.4.1 Overview
7.4.2 Support Devices: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.4.3 Microcatheters
7.4.3.1 Overview
7.4.3.2 Microcatheters: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.4.4 Guidewires
7.4.4.1 Overview
7.4.4.2 Guidewires: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
8. Middle East & Africa Embolotherapy Market Analysis – by Disease Indication
8.1 Overview
8.2 Middle East & Africa Embolotherapy Market Revenue Share, by Disease Indication 2022 & 2028 (%)
8.3 Cancer
8.3.1 Overview
8.3.2 Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.3.2.1 Liver Cancer
8.3.2.1.1 Overview
8.3.2.1.2 Liver Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.3.2.2 Kidney Cancer
8.3.2.2.1 Overview
8.3.2.2.2 Kidney Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.3.2.3 Other Cancers
8.3.2.3.1 Overview
8.3.2.3.2 Other Cancers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Peripheral Vascular Diseases
8.4.1 Overview
8.4.2 Peripheral Vascular Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Neurological Diseases
8.5.1 Overview
8.5.2 Neurological Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Urological and Nephrological Disorders
8.6.1 Overview
8.6.2 Urological and Nephrological Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Gastrointestinal Disorders
8.7.1 Overview
8.7.2 Gastrointestinal Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9. Middle East & Africa Embolotherapy Market Analysis – by Procedure
9.1 Overview
9.2 Middle East & Africa Embolotherapy Market Revenue Share, by Procedure 2022 & 2028 (%)
9.3 Transcatheter Arterial Embolization (TAE)
9.3.1 Overview
9.3.2 Transcatheter Arterial Embolization (TAE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT)
9.4.1 Overview
9.4.2 Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Transarterial Chemoembolization (TACE)
9.5.1 Overview
9.5.2 Transarterial Chemoembolization (TACE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
10. Middle East & Africa Embolotherapy Market Analysis – By End User
10.1 Overview
10.2 Middle East & Africa Embolotherapy Market Revenue Share, By End User 2022 & 2028 (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Ambulatory Surgical Centers
10.4.1 Overview
10.4.2 Ambulatory Surgical Centers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Other End Users
10.5.1 Overview
10.5.2 Other End Users: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11. Middle East & Africa Embolotherapy Market – Country Analysis
11.1 Overview
11.1.1 Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, By Country (%)
11.1.1.1 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
11.1.1.1.1 Overview
11.1.1.1.2 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
11.1.1.1.3 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)
11.1.1.1.3.1 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
11.1.1.1.3.2 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
11.1.1.1.4 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
11.1.1.1.4.1 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
11.1.1.1.5 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
11.1.1.1.6 Saudi Arabia: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
11.1.1.2 South Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
11.1.1.2.1 Overview
11.1.1.2.2 South Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
11.1.1.2.3 South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)
11.1.1.2.3.1 South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
11.1.1.2.3.2 South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
11.1.1.2.4 South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
11.1.1.2.4.1 South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
11.1.1.2.5 South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
11.1.1.2.6 South Africa: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
11.1.1.3 UAE: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
11.1.1.3.1 Overview
11.1.1.3.2 UAE: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
11.1.1.3.3 UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)
11.1.1.3.3.1 UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
11.1.1.3.3.2 UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
11.1.1.3.4 UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
11.1.1.3.4.1 UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
11.1.1.3.5 UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
11.1.1.3.6 UAE: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
11.1.1.4 Rest of Middle East and Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
11.1.1.4.1 Overview
11.1.1.4.2 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
11.1.1.4.3 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)
11.1.1.4.3.1 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
11.1.1.4.3.2 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
11.1.1.4.4 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
11.1.1.4.4.1 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
11.1.1.4.5 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
11.1.1.4.6 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
12. Middle East & Africa Embolotherapy Market –Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Boston Scientific Corporation
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Cook Medical LLC
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Johnson & Johnson
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Medtronic
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Acandis GmbH
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Balt USA LLC
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Stryker Corporation
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Guerbet LLC
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Terumo Corporation
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES.
Table 1. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)
Table 2. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
Table 3. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
Table 4. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
Table 5. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
Table 6. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
Table 7. Saudi Arabia: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 8. South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)
Table 9. South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
Table 10. South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
Table 11. South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
Table 12. South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
Table 13. South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
Table 14. South Africa: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 15. UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)
Table 16. UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
Table 17. UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
Table 18. UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
Table 19. UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
Table 20. UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
Table 21. UAE: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 22. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)
Table 23. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
Table 24. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
Table 25. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
Table 26. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
Table 27. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
Table 28. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 29. Organic Developments Done by Companies
Table 30. Inorganic Developments Done by Companies
Table 31. Glossary of Terms, Middle East & Africa Embolotherapy Market